E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with T
>
Issuers starting with T, BK only
>
All stories on TherapeuticsMD Inc.
>
Stories on TherapeuticsMD Inc., BK only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
TherapeuticsMD Inc.
3/10/2022
BKPV
TherapeuticsMD amends financing agreement with Sixth Street
12/30/2019
BKPV
TherapeuticsMD amends conditions to draw $50 million tranche
4/17/2019
BK
TherapeuticsMD signs commitment letter for $300 million term loan
6/7/2018
BK
TherapeuticsMD draws first $75 million of up to $200 million loan
5/3/2018
BK
TherapeuticsMD gets $200 million term loan spread over three tranches
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
